Evidence map›Paper›PMID 35584857›Full record

ArticleBMJ case reports2022

Superwarfarin poisoning: challenges still remain.

Ariadna de Genover Gil, Gabriel Manuel Gonzalez Suarez, Carla Moret Puig, Abelardo Hurtado Ganoza

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ariadna de Genover GilInternal Medicine, Doctor Josep Trueta University Hospital of Girona, Girona, Spain agenover.girona.ics@gencat.cat.
Gabriel Manuel Gonzalez SuarezNephrology, Doctor Josep Trueta University Hospital of Girona, Girona, Spain.
Carla Moret PuigHaematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.
Abelardo Hurtado GanozaInternal Medicine, Doctor Josep Trueta University Hospital of Girona, Girona, Spain.
Hospital Universitari de Girona Doctor Josep Trueta · ESHospital de Sant Pau · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superwarfarin (long-acting anticoagulant rodenticide) poisoning should be suspected in unexplained bleeding with prolonged prothrombin time, especially in the absence of another explanation. Diagnosis and treatment of this intoxication remain a challenge as the direct analysis of superwarfarin in serum is not always possible. Therefore, toxin bioavailability remains unknown and close monitoring and treatment for long periods are required to avoid serious bleeding complications. Here, we discuss a case of suspected superwarfarin poisoning to highlight the challenges in early diagnosis and the challenges we encountered in treatment management and ensuring compliance for long periods.

Indexed as

4-HydroxycoumarinsBlood Coagulation DisordersPoisoningRodenticidesAnticoagulantsHumans4-HydroxycoumarinsAnticoagulantsbromfenacoumRodenticidesDrugs and medicinesExposuresHaematology (incl blood transfusion)Poisoning

Identifiers

PMID35584857
PMCPMC9119149
OpenAlexW4280588218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.